Blue Jet Healthcare closes qualified institutions placement of equity shares
Blue Jet Healthcare · Pharmaceuticals & Biotechnology
Key highlights
- Allocation of 15,810,276 equity shares at ₹506.00 per share, including ₹504 premium
- Discount of ₹25.70 per share (4.83% of floor price ₹531.70) applied as per SEBI ICDR Regulations
- Placement Document dated July 9, 2026 approved and made available on company website
Why it's rated notable: The filing states no total amount, but 15,810,276 shares at ₹506.00 comes to about ₹800 crore, which is above the ₹500 crore floor for a fundraise and below 50% of the ₹10,277 crore market value, so the level is medium.
Original filing
Announcement under Regulation 30 (LODR)-Qualified Institutional Placement
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Blue Jet Healthcare
- Fundraise / allotmentMajor developmentBlue Jet Healthcare Limited announces Q2 and H1 FY2027 unaudited financial results
- Financial resultsMajor developmentBlue Jet Healthcare announces unaudited results for quarter ended September 30, 2026
- Fundraise / allotmentNotable· Adverse for the businessBlue Jet Healthcare approves Q1 FY 2026-27 results and reappointments of key leaders and auditors
- Board / shareholder meeting outcomeNotable· Adverse for the businessBlue Jet Healthcare Q1 profit ₹782.64 million; re-appointments await AGM approval
- Fundraise / allotmentNotable· Adverse for the businessBlue Jet Healthcare Limited announces Q1 FY2026-27 results and re-appointments
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.